ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Whole Genome Sequencers Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-7P17730
Home | Market Reports | Science| Biological Sciences
Global Whole Genome Sequencers Market Research Report 2024
BUY CHAPTERS

Global Whole Genome Sequencers Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-7P17730
Report
October 2025
Pages:140
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pacific Biosciences
Element Biosciences
Thermo Fisher Scientific
Roche
GeneMind
MGI Tech

Whole Genome Sequencers Market

The global Whole Genome Sequencers market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Scientific Research accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Whole Genome Sequencers leading manufacturers including Pacific Biosciences, Element Biosciences, Thermo Fisher Scientific, Illumina, Roche, GeneMind, Mgi Tech, etc., dominate supply; the top five capture approximately % of global revenue, with Pacific Biosciences leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Whole Genome Sequencers market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Whole Genome Sequencers Market Report

Report Metric Details
Report Name Whole Genome Sequencers Market
Segment by Type
  • High Depth Whole Genome Sequencing
  • Low Depth Whole Genome Sequencing
Segment by Application
  • Scientific Research
  • Clinical Medicine
  • Agriculture
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pacific Biosciences, Element Biosciences, Thermo Fisher Scientific, Illumina, Roche, GeneMind, Mgi Tech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Whole Genome Sequencers study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Whole Genome Sequencers Market report?

Ans: The main players in the Whole Genome Sequencers Market are Pacific Biosciences, Element Biosciences, Thermo Fisher Scientific, Illumina, Roche, GeneMind, Mgi Tech

What are the Application segmentation covered in the Whole Genome Sequencers Market report?

Ans: The Applications covered in the Whole Genome Sequencers Market report are Scientific Research, Clinical Medicine, Agriculture, Others

What are the Type segmentation covered in the Whole Genome Sequencers Market report?

Ans: The Types covered in the Whole Genome Sequencers Market report are High Depth Whole Genome Sequencing, Low Depth Whole Genome Sequencing

1 Study Coverage
1.1 Introduction to Whole Genome Sequencers: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Whole Genome Sequencers Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 High Depth Whole Genome Sequencing
1.2.3 Low Depth Whole Genome Sequencing
1.3 Market Segmentation by Application
1.3.1 Global Whole Genome Sequencers Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Scientific Research
1.3.3 Clinical Medicine
1.3.4 Agriculture
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Whole Genome Sequencers Revenue Estimates and Forecasts 2020-2031
2.2 Global Whole Genome Sequencers Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Whole Genome Sequencers Sales Estimates and Forecasts 2020-2031
2.4 Global Whole Genome Sequencers Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Whole Genome Sequencers Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Whole Genome Sequencers Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 High Depth Whole Genome Sequencing Market Size by Manufacturers
3.5.2 Low Depth Whole Genome Sequencing Market Size by Manufacturers
3.6 Global Whole Genome Sequencers Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Whole Genome Sequencers Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Whole Genome Sequencers Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Whole Genome Sequencers Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Whole Genome Sequencers Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Whole Genome Sequencers Sales and Revenue by Type (2020-2031)
6.4 North America Whole Genome Sequencers Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Whole Genome Sequencers Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Whole Genome Sequencers Sales and Revenue by Type (2020-2031)
7.4 Europe Whole Genome Sequencers Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Whole Genome Sequencers Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Whole Genome Sequencers Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Whole Genome Sequencers Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Whole Genome Sequencers Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Whole Genome Sequencers Sales and Revenue by Type (2020-2031)
9.4 Central and South America Whole Genome Sequencers Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Whole Genome Sequencers Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Whole Genome Sequencers Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Whole Genome Sequencers Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Whole Genome Sequencers Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Pacific Biosciences
11.1.1 Pacific Biosciences Corporation Information
11.1.2 Pacific Biosciences Business Overview
11.1.3 Pacific Biosciences Whole Genome Sequencers Product Models, Descriptions and Specifications
11.1.4 Pacific Biosciences Whole Genome Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Pacific Biosciences Whole Genome Sequencers Sales by Product in 2024
11.1.6 Pacific Biosciences Whole Genome Sequencers Sales by Application in 2024
11.1.7 Pacific Biosciences Whole Genome Sequencers Sales by Geographic Area in 2024
11.1.8 Pacific Biosciences Whole Genome Sequencers SWOT Analysis
11.1.9 Pacific Biosciences Recent Developments
11.2 Element Biosciences
11.2.1 Element Biosciences Corporation Information
11.2.2 Element Biosciences Business Overview
11.2.3 Element Biosciences Whole Genome Sequencers Product Models, Descriptions and Specifications
11.2.4 Element Biosciences Whole Genome Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Element Biosciences Whole Genome Sequencers Sales by Product in 2024
11.2.6 Element Biosciences Whole Genome Sequencers Sales by Application in 2024
11.2.7 Element Biosciences Whole Genome Sequencers Sales by Geographic Area in 2024
11.2.8 Element Biosciences Whole Genome Sequencers SWOT Analysis
11.2.9 Element Biosciences Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Corporation Information
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Whole Genome Sequencers Product Models, Descriptions and Specifications
11.3.4 Thermo Fisher Scientific Whole Genome Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Thermo Fisher Scientific Whole Genome Sequencers Sales by Product in 2024
11.3.6 Thermo Fisher Scientific Whole Genome Sequencers Sales by Application in 2024
11.3.7 Thermo Fisher Scientific Whole Genome Sequencers Sales by Geographic Area in 2024
11.3.8 Thermo Fisher Scientific Whole Genome Sequencers SWOT Analysis
11.3.9 Thermo Fisher Scientific Recent Developments
11.4 Illumina
11.4.1 Illumina Corporation Information
11.4.2 Illumina Business Overview
11.4.3 Illumina Whole Genome Sequencers Product Models, Descriptions and Specifications
11.4.4 Illumina Whole Genome Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Illumina Whole Genome Sequencers Sales by Product in 2024
11.4.6 Illumina Whole Genome Sequencers Sales by Application in 2024
11.4.7 Illumina Whole Genome Sequencers Sales by Geographic Area in 2024
11.4.8 Illumina Whole Genome Sequencers SWOT Analysis
11.4.9 Illumina Recent Developments
11.5 Roche
11.5.1 Roche Corporation Information
11.5.2 Roche Business Overview
11.5.3 Roche Whole Genome Sequencers Product Models, Descriptions and Specifications
11.5.4 Roche Whole Genome Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Roche Whole Genome Sequencers Sales by Product in 2024
11.5.6 Roche Whole Genome Sequencers Sales by Application in 2024
11.5.7 Roche Whole Genome Sequencers Sales by Geographic Area in 2024
11.5.8 Roche Whole Genome Sequencers SWOT Analysis
11.5.9 Roche Recent Developments
11.6 GeneMind
11.6.1 GeneMind Corporation Information
11.6.2 GeneMind Business Overview
11.6.3 GeneMind Whole Genome Sequencers Product Models, Descriptions and Specifications
11.6.4 GeneMind Whole Genome Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 GeneMind Recent Developments
11.7 Mgi Tech
11.7.1 Mgi Tech Corporation Information
11.7.2 Mgi Tech Business Overview
11.7.3 Mgi Tech Whole Genome Sequencers Product Models, Descriptions and Specifications
11.7.4 Mgi Tech Whole Genome Sequencers Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Mgi Tech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Whole Genome Sequencers Industry Chain
12.2 Whole Genome Sequencers Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Whole Genome Sequencers Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Whole Genome Sequencers Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Whole Genome Sequencers Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Whole Genome Sequencers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Pacific Biosciences
Element Biosciences
Thermo Fisher Scientific
Roche
GeneMind
MGI Tech
List of Tables
 Table 1. Global Whole Genome Sequencers Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Whole Genome Sequencers Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Whole Genome Sequencers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Whole Genome Sequencers Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Whole Genome Sequencers Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Whole Genome Sequencers Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Whole Genome Sequencers Sales by Region (2020-2025) & (Units)
 Table 8. Global Whole Genome Sequencers Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Whole Genome Sequencers Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Whole Genome Sequencers Sales Share by Manufacturers (2020-2025)
 Table 12. Global Whole Genome Sequencers Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Whole Genome Sequencers Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Whole Genome Sequencers by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Genome Sequencers as of 2024)
 Table 16. Global Whole Genome Sequencers Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Whole Genome Sequencers Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
 Table 18. Key Manufacturers Whole Genome Sequencers Manufacturing Base and Headquarters
 Table 19. Global Whole Genome Sequencers Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Whole Genome Sequencers Sales by Type (2020-2025) & (Units)
 Table 23. Global Whole Genome Sequencers Sales by Type (2026-2031) & (Units)
 Table 24. Global Whole Genome Sequencers Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Whole Genome Sequencers Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Whole Genome Sequencers ASP by Type (2020-2031) & (K US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Whole Genome Sequencers Sales by Application (2020-2025) & (Units)
 Table 29. Global Whole Genome Sequencers Sales by Application (2026-2031) & (Units)
 Table 30. Whole Genome Sequencers High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Whole Genome Sequencers Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Whole Genome Sequencers Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Whole Genome Sequencers ASP by Application (2020-2031) & (K US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Whole Genome Sequencers Growth Accelerators and Market Barriers
 Table 37. North America Whole Genome Sequencers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Whole Genome Sequencers Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Whole Genome Sequencers Growth Accelerators and Market Barriers
 Table 40. Europe Whole Genome Sequencers Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Whole Genome Sequencers Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Whole Genome Sequencers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Whole Genome Sequencers Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Whole Genome Sequencers Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Whole Genome Sequencers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Whole Genome Sequencers Investment Opportunities and Key Challenges
 Table 47. Central and South America Whole Genome Sequencers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Whole Genome Sequencers Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Whole Genome Sequencers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Pacific Biosciences Corporation Information
 Table 51. Pacific Biosciences Description and Major Businesses
 Table 52. Pacific Biosciences Product Models, Descriptions and Specifications
 Table 53. Pacific Biosciences Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 54. Pacific Biosciences Sales Value Proportion by Product in 2024
 Table 55. Pacific Biosciences Sales Value Proportion by Application in 2024
 Table 56. Pacific Biosciences Sales Value Proportion by Geographic Area in 2024
 Table 57. Pacific Biosciences Whole Genome Sequencers SWOT Analysis
 Table 58. Pacific Biosciences Recent Developments
 Table 59. Element Biosciences Corporation Information
 Table 60. Element Biosciences Description and Major Businesses
 Table 61. Element Biosciences Product Models, Descriptions and Specifications
 Table 62. Element Biosciences Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 63. Element Biosciences Sales Value Proportion by Product in 2024
 Table 64. Element Biosciences Sales Value Proportion by Application in 2024
 Table 65. Element Biosciences Sales Value Proportion by Geographic Area in 2024
 Table 66. Element Biosciences Whole Genome Sequencers SWOT Analysis
 Table 67. Element Biosciences Recent Developments
 Table 68. Thermo Fisher Scientific Corporation Information
 Table 69. Thermo Fisher Scientific Description and Major Businesses
 Table 70. Thermo Fisher Scientific Product Models, Descriptions and Specifications
 Table 71. Thermo Fisher Scientific Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 72. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
 Table 73. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
 Table 74. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
 Table 75. Thermo Fisher Scientific Whole Genome Sequencers SWOT Analysis
 Table 76. Thermo Fisher Scientific Recent Developments
 Table 77. Illumina Corporation Information
 Table 78. Illumina Description and Major Businesses
 Table 79. Illumina Product Models, Descriptions and Specifications
 Table 80. Illumina Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 81. Illumina Sales Value Proportion by Product in 2024
 Table 82. Illumina Sales Value Proportion by Application in 2024
 Table 83. Illumina Sales Value Proportion by Geographic Area in 2024
 Table 84. Illumina Whole Genome Sequencers SWOT Analysis
 Table 85. Illumina Recent Developments
 Table 86. Roche Corporation Information
 Table 87. Roche Description and Major Businesses
 Table 88. Roche Product Models, Descriptions and Specifications
 Table 89. Roche Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 90. Roche Sales Value Proportion by Product in 2024
 Table 91. Roche Sales Value Proportion by Application in 2024
 Table 92. Roche Sales Value Proportion by Geographic Area in 2024
 Table 93. Roche Whole Genome Sequencers SWOT Analysis
 Table 94. Roche Recent Developments
 Table 95. GeneMind Corporation Information
 Table 96. GeneMind Description and Major Businesses
 Table 97. GeneMind Product Models, Descriptions and Specifications
 Table 98. GeneMind Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 99. GeneMind Recent Developments
 Table 100. Mgi Tech Corporation Information
 Table 101. Mgi Tech Description and Major Businesses
 Table 102. Mgi Tech Product Models, Descriptions and Specifications
 Table 103. Mgi Tech Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 104. Mgi Tech Recent Developments
 Table 105. Key Raw Materials Distribution
 Table 106. Raw Materials Key Suppliers
 Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 108. Milestones in Production Technology Evolution
 Table 109. Distributors List
 Table 110. Market Trends and Market Evolution
 Table 111. Market Drivers and Opportunities
 Table 112. Market Challenges, Risks, and Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources


List of Figures
 Figure 1. Whole Genome Sequencers Product Picture
 Figure 2. Global Whole Genome Sequencers Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. High Depth Whole Genome Sequencing Product Picture
 Figure 4. Low Depth Whole Genome Sequencing Product Picture
 Figure 5. Global Whole Genome Sequencers Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Scientific Research
 Figure 7. Clinical Medicine
 Figure 8. Agriculture
 Figure 9. Others
 Figure 10. Whole Genome Sequencers Report Years Considered
 Figure 11. Global Whole Genome Sequencers Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Whole Genome Sequencers Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Whole Genome Sequencers Revenue Market Share by Region (2020-2031)
 Figure 15. Global Whole Genome Sequencers Sales (2020-2031) & (Units)
 Figure 16. Global Whole Genome Sequencers Sales (CAGR) by Region (2020-2031) (Units)
 Figure 17. Global Whole Genome Sequencers Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Whole Genome Sequencers Sales Volume Market Share in 2024
 Figure 19. Global Whole Genome Sequencers Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. High Depth Whole Genome Sequencing Revenue Market Share by Manufacturer in 2024
 Figure 22. Low Depth Whole Genome Sequencing Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Whole Genome Sequencers Sales Market Share by Type (2020-2031)
 Figure 24. Global Whole Genome Sequencers Revenue Market Share by Type (2020-2031)
 Figure 25. Global Whole Genome Sequencers Sales Market Share by Application (2020-2031)
 Figure 26. Global Whole Genome Sequencers Revenue Market Share by Application (2020-2031)
 Figure 27. North America Whole Genome Sequencers Sales YoY (2020-2031) & (Units)
 Figure 28. North America Whole Genome Sequencers Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Whole Genome Sequencers Sales Revenue (US$ Million) in 2024
 Figure 30. North America Whole Genome Sequencers Sales Volume (Units) by Type (2020- 2031)
 Figure 31. North America Whole Genome Sequencers Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Whole Genome Sequencers Sales Volume (Units) by Application (2020-2031)
 Figure 33. North America Whole Genome Sequencers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Whole Genome Sequencers Sales YoY (2020-2031) & (Units)
 Figure 38. Europe Whole Genome Sequencers Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Whole Genome Sequencers Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Whole Genome Sequencers Sales Volume (Units) by Type (2020-2031)
 Figure 41. Europe Whole Genome Sequencers Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Whole Genome Sequencers Sales Volume (Units) by Application (2020-2031)
 Figure 43. Europe Whole Genome Sequencers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 45. France Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Whole Genome Sequencers Sales YoY (2020-2031) & (Units)
 Figure 50. Asia-Pacific Whole Genome Sequencers Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Whole Genome Sequencers Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Whole Genome Sequencers Sales Volume (Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific Whole Genome Sequencers Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Whole Genome Sequencers Sales Volume (Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Whole Genome Sequencers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 60. India Whole Genome Sequencers Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Whole Genome Sequencers Sales YoY (2020-2031) & (Units)
 Figure 62. Central and South America Whole Genome Sequencers Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Whole Genome Sequencers Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Whole Genome Sequencers Sales Volume (Units) by Type (2021-2031)
 Figure 65. Central and South America Whole Genome Sequencers Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Whole Genome Sequencers Sales Volume (Units) by Application (2020-2031)
 Figure 67. Central and South America Whole Genome Sequencers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Whole Genome Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Whole Genome Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Whole Genome Sequencers Sales YoY (2020-2031) & (Units)
 Figure 71. Middle East and Africa Whole Genome Sequencers Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Whole Genome Sequencers Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Whole Genome Sequencers Sales Volume (Units) by Type (2021-2031)
 Figure 74. South America Whole Genome Sequencers Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Whole Genome Sequencers Sales Volume (Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Whole Genome Sequencers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Whole Genome Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Whole Genome Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Whole Genome Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Whole Genome Sequencers Revenue (2020-2025) & (US$ Million)
 Figure 81. Whole Genome Sequencers Industry Chain Mapping
 Figure 82. Regional Whole Genome Sequencers Manufacturing Base Distribution (%)
 Figure 83. Global Whole Genome Sequencers Production Market Share by Region (2020-2031)
 Figure 84. Whole Genome Sequencers Production Process
 Figure 85. Regional Whole Genome Sequencers Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Whole Genome Sequencing Service Market Research Report 2025
Global Genome Sequencing Service Market Research Report 2025
Global All in one DNA Sequencer Market Research Report 2024
Global Human Genome Sequencing Market Research Report 2024
Global Genome Sequencing Equipment Market Research Report 2025
Global Targeted Gene Sequencers Market Research Report 2024
Whole Genome Resequencing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genomics Services Market Research Report 2024
Global Human Gene Sequencing Market Research Report 2024
Global DNA Sequencing Platforms Market Research Report 2024
Global Sequencing Services Market Research Report 2024
Global Bioinformatics Sequencing Service Market Research Report 2024
Global Third Generation Sequencing Market Research Report 2024
Global DNA Sequencing Instruments Market Research Report 2024
Global ChIP Sequencing Market Research Report 2025
Global Full length Transcriptome Sequencing Market Research Report 2024
Global DNA Sequence Analysis Software Market Research Report 2025
Global Epigenome Sequencing Market Research Report 2024
Global Genome Annotation Service Market Research Report 2024
Global Protein Sequencer Market Insights Forecast to 2030

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B20127
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36H20013
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7C20305
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13N20234
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions